The Honorable Shirley Ann Jackson, Ph.D., cordially invites you to the

Opening of the Center for Biotechnology and Interdisciplinary Studies

Opportunities at the Interface of Bioscience and Bioengineering

AN ENGAGING DISCUSSION ON THE INTERSECTION OF THE LIFE SCIENCES, TECHNOLOGY, AND POLICY

Friday, September 10, 2004 8:30 – 10:30 a.m. Academy Hall Auditorium, 15th Street and College Avenue

	Bruce Alberts, Ph.D., President, National Academy of Sciences, and Chair, National Research Council, is a respected biochemist recognized for his work both in biochemistry and molecular biology, particularly for his extensive study of the protein complexes that allow chromosomes to be replicated.			James C. Mullen ’80, President and CEO, Biogen Idec Inc., was formerly Chairman of the Board and Chief Executive Officer of Biogen. He was named Chairman of the Board of Directors in July 2002, after being named President and CEO of Biogen in June 2000.
	Claire M. Fraser ’77, Ph.D., President and Director, The Institute for Genomic Research, led the teams that sequenced the genomes of Mycoplasma genitalium, the spirochetes Treponema pallidum and Borrelia burgdorferi, and two species of Chlamydia.			William Wulf, Ph.D., President, National Academy of Engineering, has conducted research on computer architecture, computer security, programming languages, and optimizing compilers. He also serves as the vice chair of the National Research Council.
	William A. Haseltine, Ph.D., Chairman and CEO, Human Genomic Sciences Inc., has a distinguished record of academic achievement in both cancer and AIDS research. Haseltine is a member of the board of the Biotechnology Industry Organization, the Brookings Institution, the Council on Foreign Relations, and many other notable policy organizations.			Elias Zerhouni, M.D., Director, National Institutes of Health (NIH), initiated the creation of a new research vision for the NIH that focuses the attention of the biomedical research community on new pathways of discovery, research teams for the future, and the re-engineering of the clinical research enterprise.

Hosted by the Honorable Shirley Ann Jackson, Ph.D.